• All
  • Important
  • Financial Update
  • Fund Raise
  • Board Meeting
  • Dividend/Bonus
  • JV/Acquisition
  • Investor Meet
  • Insider Trade
  • Pledging
  • Others
    ALPHA TRIBE

    Cohance Lifesciences Limited — Updates, 03-09-2026: Press Release

    03-09-2026 | 08:09 pm

    Cohance Lifesciences advances its ADC strategy with a USD 13 million additional investment in NJ Bio and a USD 5 million controlling investment in Aruka Bio. This reorganisation, funded by internal accruals, strengthens integration and pipeline development.

    No comments yet. Be the first to comment!

    All announcements from Cohance Lifesciences Limited